Clinical Trials Directory

Trials / Completed

CompletedNCT04109911

Effect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia Adults

Effect of Fermented Oyster Extract on Musculoskeletal Biomarkers in Relative Sarcopenia Adults: a Randomized, Double-blinded, Placebo-controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Pusan National University Yangsan Hospital · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the fermented oyster extract on muscle strength, muscle mass, and muscle function in healthy adults for 12 weeks.

Detailed description

Previous studies have indicated that fermented oyster extract may have the ability to prevent skeletal muscle atrophy. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the fermented oyster extract on muscle strength, muscle mass, and muscle function in healthy adults; the safety of the compound are also evaluate. The Investigators examine the peak torque/body weight at 60°/s knee extension, handgrip strength, skeletal muscle mass, physical performance, and metabolic parameters at baseline, as well as after 4 and 12 weeks of intervention. Fifty-four healthy adults were administered either 1,200 mg of fermented oyster extract or a placebo each day for 12 weeks;

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFermented oyster extractFermented oyster extract 1,200 mg/day for 12 weeks
DIETARY_SUPPLEMENTPlaceboPlacebo

Timeline

Start date
2019-09-25
Primary completion
2020-05-04
Completion
2020-12-31
First posted
2019-10-01
Last updated
2022-04-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04109911. Inclusion in this directory is not an endorsement.